Searched for
MALARIA RESEARCH AND DEVELOPMENT
Avience Biomedicals IPO: Check GMP, price band and other detailsThe grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Ancient disease pressures may have driven early human migration patternsNew research reveals malaria's profound impact on early human settlements across Africa. Scientists used advanced models to show how diseas...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Oxford University strikes new malaria vaccine pact with Serum Institute of IndiaOxford University and Serum Institute of India are collaborating on a new malaria vaccine, R78C. This partnership aims to create a more eff...
- Anthropic appoints Indian-origin Novartis CEO Vas Narasimhan to its boardAnthropic’s Long-Term Benefit Trust is an independent governance body, designed to insulate key decisions as it scales its frontier AI syst...
- Development of indigenous multi-stage Malaria vaccine 'AdFalciVax' is underwayIndia is developing a new malaria vaccine. The Indian Council of Medical Research is leading the effort. The vaccine is called AdFalciVax. ...
- WHO approved a malaria vaccine for children – a global health expert explains why that is a big dealApproval of the RTS,S/AS01 vaccine, which goes by the name Mosquirix, provides a "glimmer of hope" for Africa, according to Dr. Matshidiso ...
- Effective malaria treatment a step closerThe discovery could potentially make malaria treatment significantly more effective for the 3.2 billion people at risk.
- New malaria vaccine generates robust immune responseA new malaria vaccine candidate has been found to generate robust immune response while significantly delaying parasitemia in 59 per cent o...
- 'Self-sabotage' prevents immune protection against malariaMalaria parasites cause an inflammatory reaction that sabotages our body's ability to protect itself against the deadly disease, scientists...
- Dams contribute to one million malaria cases in Africa annuallyThe study has for the first time correlated the location of large dams with the incidence of malaria and quantified impacts across the regi...
- Malaria increases risk of blood cancer in childrenThe parasite that causes malaria infects red blood cells and liver cells, while Burkitt's lymphoma originates in infection-fighting white b...
- Cipla Ltd, Strides Arcolab signs collaboration agreements with Medicines for Malaria VentureCipla and Strides will develop a product building on the clinical studies led by TDR, the special programme for research and training in tr...
- Malaria research requires USD 8.3 billion: ReportThe study warns that R&D investments are critical, given the emergence of drug resistance in the malaria parasite and insecticide resistanc...
- Drug to offer 'single-dose' malaria cure foundScientists claim to have discovered a drug that could cure all strains of malaria with a single oral dose and also block transmission of th...
- Drug-resistant malaria may spread, India warnedA new research has warned that drug-resistant malaria parasites on the border of Thailand & Myanmar may spread to India.
- Bill Gates invests in chewing gum, chocolate to combat malariaBill Gates believes chewing gum and chocolate could become the next tool to combat malaria.
- Ranbaxy set to launch India's first malaria drugDrug major Ranbaxy has successfully completed the phase II clinical trials for the first malaria drug being developed in the country.
- Ranbaxy completes phase II trials for anti-malaria drugRanbaxy has succesfully completed the phase II clinical trials for the first malaria drugs being developed in India since many decades and ...
Load More
